✦ LIBER ✦

Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia

✍ Scribed by A. Hellmann; K. Lewandowski; J.M. Zaucha; M. Bieniaszewska; K. Hałaburda; T. Robak

Book ID: 114792560
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 629 KB
Volume: 63
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1999.tb01848.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of 2-h infusion of 2-chlorode

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia

✍ T Robak; M Błasińska-Morawiec; J.Z Błoński; E Krykowski; M Komarnicki; E Trepińs 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A new parameter of the tumor lysis syndr

A new parameter of the tumor lysis syndrome: Marked increase in serum IgM M-component in two patients with waldenström's macroglobulinemia (WM) treated with 2-chlorodeoxyadenosine (cladribine)

✍ Krishna, Vandana M; Bloch, Kurt J; Carey, Robert W 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

2-Chlorodeoxyadenosine in the treatment

2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders

✍ D. Rondelli; F. Lauria; P. L. Zinzani; D. Raspadori; M. A. Ventura; P. Galieni; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB

2-chlorodeoxyadenosine (2-CDA) for the t

2-chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients

✍ Stine, Kimo C.; Saylors, Robert L.; Williams, Laura L.; Becton, David L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Background. Pediatric patients with Langerhans cell histiocytosis (LCH) may become refractory to conventional therapy or present with repeated recurrences over several years. Current therapeutic options such as prednisone, vinblastine, etoposide, and cyclosporine are associated with significant acut

A phase II open-label study of DHA-pacli

A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma

✍ Robert J. Jones; Robert E. Hawkins; Martin M. Eatock; David R. Ferry; Ferry A. L 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 265 KB

Pilot trial of intravenous infusion of a

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

✍ Nemunaitis, J; Cunningham, C; Tong, A W; Post, L; Netto, G; Paulson, A S; Rich, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 201 KB